Antidepressants cause insomnia primarily because they increase serotonin levels in the brain, and serotonin is a chemical that promotes wakefulness. This creates a paradox: the same mechanism that helps lift depression can also make it harder to fall asleep or stay asleep. Roughly 6% of people taking SSRIs or SNRIs experience insomnia as a side effect, though individual rates range from as low as 1.5% to as high as 25% depending on the specific medication.
Serotonin’s Role in Wakefulness
Serotonin is often associated with mood, but it also plays a major role in regulating sleep and wakefulness. It predominantly promotes wakefulness and suppresses REM sleep, the deep dreaming stage your brain cycles through several times each night. When an antidepressant raises serotonin levels in the gaps between nerve cells, it doesn’t just improve mood. It also activates several types of serotonin receptors that keep you alert.
This applies to most mainstream antidepressants. SSRIs, SNRIs, tricyclics, and MAO inhibitors all increase the amount of serotonin available in the brain. The stimulation of multiple serotonin receptor subtypes increases wakefulness while reducing both slow-wave sleep (the deepest, most restorative stage) and REM sleep. Your brain essentially gets a wakefulness signal at times when it should be winding down.
How Antidepressants Reshape Your Sleep Stages
Beyond simple difficulty falling asleep, antidepressants fundamentally alter sleep architecture. Most antidepressants suppress REM sleep, sometimes dramatically. In research comparing common SSRIs, acute treatment with paroxetine and citalopram each suppressed REM sleep by about 84% compared to a placebo, while imipramine (a tricyclic) reduced it by roughly 69%. That’s a massive reduction in a sleep stage your brain relies on for memory consolidation and emotional processing.
Interestingly, this REM suppression is generally well tolerated. People don’t typically feel the loss of REM sleep as acutely as they feel the difficulty falling asleep or the frequent nighttime awakenings. But the two SSRIs studied (paroxetine and citalopram) didn’t allow full recovery of the lost REM sleep even after the drug cleared the system, while imipramine did. This suggests that different antidepressants vary in how completely the brain can bounce back from their sleep-disrupting effects.
Why Bupropion Is Especially Activating
Bupropion works differently from SSRIs. Instead of targeting serotonin, it blocks the reuptake of dopamine and norepinephrine, two chemicals closely linked to alertness and motivation. While it’s not a classic stimulant, its ability to boost these neurotransmitters produces a stimulating effect that can include restlessness, activation, and difficulty sleeping. These effects tend to peak when the drug reaches its highest concentration in the blood.
Timing matters with bupropion. The stimulating effects correlate directly with peak blood levels of the drug. Taking the extended-release formulation in the morning pushes those peak levels earlier in the day, away from bedtime, which appears to lower the risk of insomnia. For people taking shorter-acting versions or dosing later in the day, the stimulating effects can land right when they’re trying to sleep.
SNRIs Add a Second Stimulating Layer
SNRIs like venlafaxine and duloxetine raise both serotonin and norepinephrine. Norepinephrine is one of the brain’s primary alertness chemicals. It activates the systems that keep you awake and responsive to your environment. So SNRIs deliver a double hit to sleep: serotonin promoting wakefulness through one set of pathways, and norepinephrine doing the same through another. This is why SNRIs sometimes carry a higher risk of insomnia than SSRIs alone, though individual responses vary considerably.
When the Insomnia Typically Fades
For many people, antidepressant-related insomnia improves within the first few weeks of treatment. The brain gradually adjusts to the new levels of neurotransmitters, and sleep patterns often stabilize as this adaptation occurs. However, “weeks” is vague for a good reason: the timeline varies depending on the medication, the dose, and your individual biology. Some people find their sleep normalizes in two to three weeks, while others deal with disrupted sleep for longer, particularly if the dose is increased.
If insomnia persists beyond the initial adjustment period, the issue is worth raising with your prescriber. There are several practical options: shifting the dose to the morning, adjusting the dose itself, or switching to a different medication with a lower insomnia profile.
Antidepressants That Are Less Likely to Disrupt Sleep
Not all antidepressants push toward wakefulness. Some have the opposite effect, and they’re often chosen specifically for people who have both depression and insomnia.
- Mirtazapine increases serotonin and norepinephrine but also acts on histamine receptors, which produces a strong sedative effect. It’s frequently prescribed when insomnia accompanies depression or anxiety.
- Trazodone was originally developed as an antidepressant but is now commonly prescribed at lower doses specifically for sleep. Its sedating properties are well known, though debate continues about its effectiveness as a long-term sleep solution.
- Amitriptyline, a tricyclic antidepressant, carries a lower risk of insomnia and is more likely to cause drowsiness. It’s widely used in clinical practice for sleep problems, even though it isn’t officially approved for that purpose.
The key difference with these medications is their interaction with histamine receptors. Histamine is another wakefulness chemical (it’s the same one that antihistamines like diphenhydramine block to make you drowsy). Antidepressants that block histamine receptors tend to cause sedation rather than insomnia, which can be a useful tradeoff for people whose depression comes with severe sleep disruption.
What You Can Do About It
If you’re experiencing insomnia from an antidepressant, the most effective first step is adjusting when you take it. Activating medications like SSRIs, SNRIs, and bupropion are generally better tolerated when taken in the morning, keeping their peak stimulating effects well before bedtime. This single change resolves the problem for some people entirely.
Standard sleep hygiene practices also help offset the activating effects: keeping a consistent wake time, avoiding screens in the hour before bed, and limiting caffeine after midday. These strategies won’t override a strong pharmacological effect, but they reduce the additional burden on a sleep system that’s already being pushed toward wakefulness. If the insomnia is severe or persists past the first month, switching to one of the more sedating antidepressants is a reasonable option that doesn’t mean giving up on treating the underlying depression.